Adelaide Research & Scholarship: Search

Search

Results 1-10 of 16 (Search time: 0.004 seconds).

previous
1
2
next

Item hits:

Preview	Issue Date	Title	Author(s)
	1998	Responses to discussion groups for family care-givers in schizophrenia: who benefits from what?	Winefield, H.; Barlow, J.; Harvey, E.
	2003	Violence, self-harm, victimisation and homelessness in patients admitted to an acute inpatient unit in South Australia	Ash, D.; Galletly, C.; Haynes, J.; Braben, P.
	2019	Dysregulation of kynurenine metabolism is related to proinflammatory cytokines, attention, and prefrontal cortex volume in schizophrenia	Kindler, J.; Lim, C.K.; Weickert, C.S.; Boerrigter, D.; Galletly, C.; Liu, D.; Jacobs, K.R.; Balzan, R.; Bruggemann, J.; O'Donnell, M.; Lenroot, R.; Guillemin, G.J.; Weickert, T.W.
	2014	QTc prolongation with asenapine	Kotasek, F.; Tibrewal, P.; Dhillon, R.
	2019	Investigation of peripheral complement factors across stages of psychosis	Laskaris, L.; Zalesky, A.; Weickert, C.S.; Di Biase, M.A.; Chana, G.; Baune, B.T.; Bousman, C.; Nelson, B.; McGorry, P.; Everall, I.; Pantelis, C.; Cropley, V.
	2009	Clozapine use in treatment-resistant agitation in the setting of dementia	Bastiampillai, T.; Dhillon, R.; French, T.
	2012	Reasoning heuristics across the psychosis continuum: the contribution of hypersalient evidence-hypothesis matches	Balzan, R.; Delfabbro, P.; Galletly, C.; Woodward, T.
	2003	Olanzapine vs risperidone in the management of schizophrenia: a randomized double-blind trial in Australia and New Zealand	Gureje, O.; Miles, W.; Keks, N.; Grainger, D.; Lambert, T.; McGrath, J.; Tran, P.; Catts, S.; Fraser, A.; Hustig, H.; Andersen, S.; Crawford, A.
	2012	Managing clozapine discontinuation - acute and chronic maintenance strategies	Shields, M.; Bastiampillai, T.; Mohan, T.
	2011	Caffeine induced psychotic exacerbation	Tibrewal, P.; Dhillon, R.